ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Dissecting Functional uORFs as a Source of Cancer Genes in High-Risk Medulloblastoma||Dana-Farber Cancer Institute / John Prensner, MD/PhD||Young Investigator Grants||2021||Massachusetts|
|Choline Kinase and Alkylating Agent Resistance in Refractory Childhood Leukemias||Boston Children's Hospital / Alejandro Gutierrez, MD||Innovation Grants||2021||Massachusetts|
|Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma||Dana-Farber Cancer Institute / Riaz Gillani, MD||Young Investigator Grants||2021||Massachusetts|
|Loss of ER-mitochondria contacts drives therapy resistance in neuroblastoma||Children's Hospital of Philadelphia / Michael Hogarty, MD||Innovation Grants||2021||Pennsylvania|
|Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma||Seattle Children's Hospital / Shireen Ganapathi, MD||Young Investigator Grants||2021||Washington|
|Targeting tumor associated macrophages in metastatic Ewing sarcoma (ES)||New York Medical College / Mitchell Cairo, MD||Innovation Grants||2021||New York|
|The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma||Emory University / Shubin Shahab, MD/PhD||Young Investigator Grants||2021||Georgia|
|A leukemia organoid platform for dissection and targeting of tumor-niche interactions||Columbia Institute for Cancer Genetics / Adolfo Ferrando, MD/PhD||Innovation Grants||2021||New York|
|Phosphopeptides as shared targets for donor derived T cell therapy of AML||Memorial Sloan-Kettering Cancer Center / Richard O'Reilly, MD||Innovation Grants||2021||New York|
|Role of H3.3-G34R mutation in pediatric high-grade glioma||University of Texas M.D. Anderson Cancer Center / Jian Hu, PhD||Innovation Grants||2021||Texas|